Sökning: onr:"swepub:oai:gup.ub.gu.se/318557" >
Treatment with Core...
-
Stenmark, FredrikGothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för urologi,Institute of Clinical Sciences, Department of Urology,Univ Gothenburg, Sweden; Kalmar Cty Hosp, Sweden
(författare)
Treatment with CoreTherm in 570 patients with prostate volumes of 80-366 ml: an evaluation of short- and long-term retreatment risk
- Artikel/kapitelEngelska2022
Förlag, utgivningsår, omfång ...
-
2022-08-08
-
Medical Journals Sweden AB,2022
Nummerbeteckningar
-
LIBRIS-ID:oai:gup.ub.gu.se/318557
-
https://gup.ub.gu.se/publication/318557URI
-
https://doi.org/10.1080/21681805.2022.2108139DOI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-187723URI
Kompletterande språkuppgifter
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Introduction CoreTherm (ProstaLund AB, Lund, Sweden) is an outpatient treatment option in men with lower urinary tract symptoms and catheter-dependent men with chronic urinary retention caused by benign prostatic obstruction (BPO). CoreTherm is high-energy transurethral microwave thermotherapy with feedback technique. Modern treatment with CoreTherm includes transurethral intraprostatic injections of mepivacaine and adrenaline via the Schelin Catheter (ProstaLund AB, Lund, Sweden) and is often referred to as the CoreTherm Concept. Objectives The aim of this study was to evaluate the short- and long-term retreatment risk in men with large prostates and BPO or chronic urinary retention, all primarily treated with CoreTherm. Material and Methods All men from the same geographical area with prostate volumes >= 80 ml treated 1999-2015 with CoreTherm and having BPO or were catheter-dependent due to chronic urinary retention, were included. End of study period was defined as December 31, 2019. Results We identified and evaluated 570 men treated with CoreTherm, where 12% (71 patients) were surgically retreated during the follow-up. Mean follow-up was 11 years, and maximum follow-up was 20 years. The long-term retreatment rate in our study was 23%. A majority of these could be retreated with CoreTherm or TURP, with only 3% requiring open surgery. Conclusion We conclude that CoreTherm is a suitable outpatient treatment option in patients with profoundly enlarged prostates, regardless of age, prostate size, and reason for treatment.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Brudin, LarsLinköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Kalmar Cty Hosp, Sweden(Swepub:liu)larbr27
(författare)
-
Kjölhede, Henrik,1981Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för urologi,Institute of Clinical Sciences, Department of Urology,Univ Gothenburg, Sweden(Swepub:gu)xkjohe
(författare)
-
Peeker, Ralph,1958Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för urologi,Institute of Clinical Sciences, Department of Urology,Univ Gothenburg, Sweden(Swepub:gu)xpeera
(författare)
-
Stranne, Johan,1970Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för urologi,Institute of Clinical Sciences, Department of Urology,Univ Gothenburg, Sweden(Swepub:gu)xstraj
(författare)
-
Göteborgs universitetInstitutionen för kliniska vetenskaper, Avdelningen för urologi
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Scandinavian Journal of Urology: Medical Journals Sweden AB56:4, s. 336-3412168-18052168-1813
Internetlänk
Hitta via bibliotek
Till lärosätets databas